SCHEMBL3107372

SCHEMBL3107372

CCCCCCCCCCCCN(CCC)c1ccccc1[N+](=O)[O-]

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH3A1 P30838 1/20 0.51
HCAR3 P49019 1/20 0.50
VCAM1 P19320 1/20 0.41
KCNH2 Q12809 1/20 0.41
CYP3A4 P08684 2/20 0.40
MAPK1 P28482 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
TSHR P16473 1/20 0.40
MAPT P10636 1/20 0.40
TXNRD1 Q16881 2/20 0.40
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39
GSR P00390 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ALDH1A1 P00352 2/20 0.38
LMNA P02545 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TP53 P04637 2/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11570967 0.91 ALDH3A1 (0.59) ALDH3A1HCAR3CYP3A4MAPK1TDP1
SCHEMBL9011356 0.84 MAPT (0.48) HCAR3VCAM1KCNH2MAPTTXNRD1
SCHEMBL7174989 0.80 MAPT (0.38) ALDH3A1HCAR3VCAM1KCNH2CYP3A4
SCHEMBL8165221 0.79 TP53 (0.47) HCAR3VCAM1BCHEACHEALDH1A1
SCHEMBL7567118 0.78 ALDH3A1 (0.53) ALDH3A1HCAR3VCAM1KCNH2CYP3A4
SCHEMBL4365845 0.77 ALDH3A1 (0.57) ALDH3A1HCAR3MAPK1TDP1TSHR
SCHEMBL414469 0.77 ALDH3A1 (0.51) ALDH3A1HCAR3VCAM1CYP3A4MAPK1
SCHEMBL9798892 0.77 KCNH2 (0.47) KCNH2MAPTALDH1A1TP53KMT2A
Hexane SCHEMBL27460259 0.77 HSD17B10 (0.56) TDP1TSHRMAPTHSD17B10ALDH1A1
SCHEMBL27758107 0.76 MAPT (0.42) ALDH3A1HCAR3VCAM1CYP3A4MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8946302-B2 Selective sigma-1 receptor ligands WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2015-02-03 US disclosed
US-20130102571-A1 SELECTIVE SIGMA-1 RECEPTOR LIGANDS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2013-04-25 US disclosed
US-8349898-B2 Sigma-1 receptor ligands and methods of use WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2013-01-08 US disclosed
US-20100179111-A1 SIGMA-1 RECEPTOR LIGANDS AND METHODS OF USE WARF - WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2010-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179111-A1 SIGMA-1 RECEPTOR LIGANDS AND METHODS OF USE SIGMAR1, OPRL1, OPRK1 ALDH3A1 2231/4885HCAR3 204/4885VCAM1 394/4885
US-20130102571-A1 SELECTIVE SIGMA-1 RECEPTOR LIGANDS SIGMAR1, OPRL1, OPRK1 ALDH3A1 2266/4885HCAR3 197/4885VCAM1 420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.